P/E at 65.49 vs Industry's 66.26: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: A Slight Discount to Industry Average

The current P/E of 65.49 for Apollo Hospitals Enterprise Ltd. sits just below the hospital sector’s average of 66.26. This near-parity suggests the market values the company in line with its peers, reflecting expectations of steady earnings growth consistent with the sector. The premium that once existed has narrowed, signalling a more cautious approach by investors despite the company’s large-cap stature and dominant market position. This valuation alignment invites scrutiny of whether the stock’s price fully captures its earnings potential or if it is pricing in sector-wide risks. Apollo Hospitals’s P/E ratio, while high in absolute terms, is typical for the hospital industry, which often commands elevated multiples due to growth prospects and defensive characteristics.

Performance Across Timeframes: Strong Long-Term Gains with Mixed Recent Momentum

Examining returns over various periods reveals a compelling story. Over one year, Apollo Hospitals has surged 24.52%, significantly outperforming the Sensex’s 2.19% decline. The three-month return is even more striking, with a 15.39% gain compared to the Sensex’s modest 1.05% rise, indicating strong recent momentum rather than a slowdown. However, the one-week performance shows a slight dip of 0.40%, underperforming the Sensex’s 1.09% gain, suggesting some short-term profit-taking or consolidation. Year-to-date, the stock has appreciated 27.09%, contrasting with the Sensex’s 7.56% loss, reinforcing its status as a relative outperformer in 2026. Apollo Hospitals’s long-term track record is equally impressive, with five-year returns of 118.88% versus the Sensex’s 45.14%, and a ten-year gain of 557.71% compared to the Sensex’s 180.56%, underscoring its sustained growth trajectory.

Moving Average Configuration: Bullish Across All Key Averages

The technical setup for Apollo Hospitals is notably strong, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This comprehensive positioning indicates a sustained uptrend across short, medium, and long-term horizons. Such a configuration typically signals robust investor confidence and momentum, reducing the likelihood of immediate downside risk. The stock’s proximity to its 52-week high—just 4.27% away—further supports the view of a resilient technical profile. However, the high intraday volatility of 462.98% suggests that while the trend is upward, price swings remain significant, warranting close monitoring. The 0.45% gain on the latest trading day, outperforming the sector by 0.44%, adds to the evidence of positive near-term sentiment. Apollo Hospitals’s technical strength raises the question: is this momentum sustainable or nearing a peak?

Sector Context: Hospital Industry Shows Mixed Results

The hospital sector, within which Apollo Hospitals operates, has experienced a varied performance landscape. While the industry P/E remains elevated at 66.26, reflecting growth expectations, sector results have been mixed with some companies reporting flat or negative returns amid regulatory pressures and rising costs. Against this backdrop, Apollo Hospitals’s ability to maintain a valuation close to the sector average while delivering superior returns highlights its relative operational strength. The stock’s outperformance over multiple timeframes suggests it is capturing a larger share of sector growth, but the broader industry challenges temper exuberance. How will sector headwinds influence the stock’s trajectory going forward?

Rating Reassessment: Previously Hold, Now Reassessed

On 11 May 2026, Apollo Hospitals Enterprise Ltd. had its rating updated from Hold, reflecting a reassessment of its fundamentals and market position. The previous Mojo Score of 75.0 accompanied the Hold rating, indicating a solid but cautious outlook at that time. The current data, including strong relative performance and a robust technical setup, suggests a more favourable view, though the exact rating is undisclosed. This shift invites investors to consider what is the current rating? The reassessment aligns with the company’s consistent earnings growth and market leadership, but also factors in valuation and sector dynamics.

Collective Data Insights: Balancing Valuation and Momentum

The comprehensive data on Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap stock trading at a valuation closely aligned with its sector, supported by strong long-term and recent performance. The stock’s position above all major moving averages confirms a bullish technical stance, while its proximity to a 52-week high underscores sustained investor interest. Despite some short-term volatility and a minor weekly dip, the overall momentum remains positive. The rating update from Hold to a reassessed status reflects this evolving outlook, though the precise direction remains undisclosed. Investors may find it pertinent to ask should investors in Apollo Hospitals hold, buy more, or reconsider?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →